Barot BS et al. |
Physicochemical and structural characterization of iron-sucrose formulations: a comparative study. |
2014 |
Pharm Dev Technol |
pmid:23701359
|
Perelló MF et al. |
Intravenous ferrous sucrose versus placebo in addition to oral iron therapy for the treatment of severe postpartum anaemia: a randomised controlled trial. |
2014 |
BJOG |
pmid:24423186
|
Toyokuni S |
Iron overload as a major targetable pathogenesis of asbestos-induced mesothelial carcinogenesis. |
2014 |
Redox Rep. |
pmid:24257681
|
Onken JE et al. |
Ferric carboxymaltose in patients with iron-deficiency anemia and impaired renal function: the REPAIR-IDA trial. |
2014 |
Nephrol. Dial. Transplant. |
pmid:23963731
|
Shah RB et al. |
Pharmaceutical characterization and thermodynamic stability assessment of a colloidal iron drug product: iron sucrose. |
2014 |
Int J Pharm |
pmid:24440404
|
Tiwari P and Gupta KP |
Modulation of miR-203 and its regulators as a function of time during the development of 7, 12 dimethylbenz [a] anthracene induced mouse skin tumors in presence or absence of the antitumor agents. |
2014 |
Toxicol. Appl. Pharmacol. |
pmid:24792773
|
Agarwal R et al. |
A randomized trial of intravenous and oral iron in chronic kidney disease. |
2015 |
Kidney Int. |
pmid:26083656
|
Connor JR et al. |
Comparative evaluation of nephrotoxicity and management by macrophages of intravenous pharmaceutical iron formulations. |
2015 |
PLoS ONE |
pmid:25973894
|
Bhandari S et al. |
A randomized, open-label trial of iron isomaltoside 1000 (Monofer®) compared with iron sucrose (Venofer®) as maintenance therapy in haemodialysis patients. |
2015 |
Nephrol. Dial. Transplant. |
pmid:25925701
|
Toblli JE et al. |
Cardiovascular outcomes of intravenous iron in perspective of clinical trials and the use of different iron preparations. |
2015 |
Int. J. Cardiol. |
pmid:25838213
|